Newsroom | 10798 results

Sorted by: Latest

Surgery
-

Butterfly Network Reports First Quarter 2025 Financial Results

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the first quarter ended March 31, 2025, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, “2025 is off to a great start. The Butterfly team hit the mark...
-

ATEC Reports First Quarter 2025 Financial Results and Raises Full-Year Guidance

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2025, and recent corporate highlights. First Quarter 2025 Financial Results   Quarter Ended March 31, 2025 Total revenue $169 million GAAP gross margin 69% Non-GAAP gross margin 70% GAAP operating expenses $160 million Non-GAAP operating expenses $124 million GAA...
-

Award-Winning HSS Study Uses AI to Identify Risk Factors Linked to More Severe Pain After Knee Replacement

ORLANDO, Fla.--(BUSINESS WIRE)--A study using artificial intelligence to classify patient pain archetypes and identify risk for severe pain after knee replacement has earned a Best of Meeting award at the 50th Annual Meeting of the American Society of Regional Anesthesia and Pain Medicine (ASRA). The honor, which recognizes excellence in scientific research, is awarded to three of the top 10 highest-scoring abstracts chosen by the ASRA Research Committee. “It is an honor to have one of the top...
-

Ora Unveils Breakthrough Clinical Trial Innovations at ARVO 2025

BOSTON--(BUSINESS WIRE)--Leading global ophthalmology CRO Ora announces participation in ARVO 2025, including 2 podium presentations and 10 accepted posters...
-

Baxter Reports First-Quarter 2025 Results

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2025. “Our solid performance in the first quarter of 2025 reflects the ongoing impact of our transformation journey,” said Brent Shafer, chair and interim chief executive officer. “Baxter today is a more focused and agile organization, well positioned to drive enhanced value for patients, healthcare providers, customers and shareholders through our rei...
-

Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that its Nanosecond PFA technology will be featured in a presentation and a preclinical poster featuring the nsPFA Cardiac Surgical System at the American Association for Thoracic Surgery (AATS) 2025 Annual Meeting, being held May 2-5 in Seattle, Washington. “We believe the Nanosecond PFA...
-

CONMED Corporation Announces First Quarter 2025 Financial Results

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Sales of $321.3 million increased 2.9% year-over-year as reported and 3.8% in constant currency. Domestic revenue increased 4.2% year-over-year. International revenue increased 1.2% year-over-year as reported and 3.4% in constant currency. Diluted net earnings per share (GAAP) were $0.19, compared to diluted net earnings per sh...
-

CareDx Reports First Quarter 2025 Results

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) today reported financial results for the first quarter ended March 31, 2025. First Quarter Financial Highlights Reported first quarter revenue of $84.7 million, increased 18% year-over-year Testing services revenue of $61.9 million, increased 15% year-over-year, and testing services volume of approximately 47,100, increased 12% year-over-year GAAP net loss of $10.4 million, non-GAAP net income of $5.4 million, and positive adjusted...
-

Stromal Vascular Fraction Market Tariff Impact Analysis Report 2025: Analysis of Cost and Supply Chain Implications by Sourcing and Trade Exposure - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Stromal Vascular Fraction - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Stromal Vascular Fraction was valued at US$98.2 Million in 2024 and is projected to reach US$127.8 Million by 2030, growing at a CAGR of 4.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the mos...
-

Premier Anesthesia Partners with Holzer Health System to Enhance Anesthesia Services Across Southeast Ohio

ALPHARETTA, Ga.--(BUSINESS WIRE)--Premier Anesthesia, one of the nation’s oldest and largest privately held, single-specialty anesthesia practice management companies, today announced its new partnership with four key facilities in the Holzer Health System: Holzer Gallipolis, Holzer Gallipolis Surgery Center, Holzer Jackson and Holzer Athens Surgery Center. This collaboration underscores Premier Anesthesia’s continued commitment to expanding in the region by partnering with hospitals and surger...